| Cibus, Inc. (CBUS) Q1 2025 Earnings Call Transcript |
Cibus, Inc. (NASDAQ:CBUS ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Carlo Broos - Interim CFO Peter Beetham - Co-Founder, Interim CEO, President, COO & Director Gregory Gocal - Co-Founder, Chief Scientific Officer & EVP Conference Call Participants Laurence Alexander - Jefferies Austin Moeller - Canaccord Sameer Joshi - H.C. Wainwright Matthew Venezia - AGP Operator Good afternoon, and welcome to the Cibus 1Q '25 Earnings Call. |
seekingalpha.com |
2025-05-10 21:17:24 |
Czytaj oryginał (ang.) |
| Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates |
Cibus (CBUS) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $1.12 per share a year ago. |
zacks.com |
2025-05-08 23:25:37 |
Czytaj oryginał (ang.) |
| Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025 |
Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture a nd Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional b reeding Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS technologies enabling novel approach to combating yield losses and generating significant commercial interest USDA-APHIS designates Canola disease resistance traits as not regulated; Confirmation validates US regulatory treatment of Cibus' RTDS technologies and strengthens commercial pathway First quarter also saw the EU member states endorse the EU Council's negotiating mandate on the regulation of plants obtained by New Genomic Techniques (NGTs), enabling trilogue discussions (EU Parliament, Commission, and Council) on the text of the legislation to be proposed for final adoption SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced its financial results for the quarter ended March 31, 2025, and provided a year-to-date business update for 2025. Management will host a conference call and webcast today at 4:30 p.m. |
globenewswire.com |
2025-05-08 20:05:00 |
Czytaj oryginał (ang.) |
| Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding |
Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and eventual commercialization in a key Rice growing region Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and eventual commercialization in a key Rice growing region |
globenewswire.com |
2025-05-07 11:00:00 |
Czytaj oryginał (ang.) |
| Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
Cibus (CBUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-05-01 15:07:45 |
Czytaj oryginał (ang.) |
| Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call |
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2025 financial results on Thursday, May 8, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. |
globenewswire.com |
2025-04-25 11:00:00 |
Czytaj oryginał (ang.) |
| USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated |
Designation confirms conventional regulation of Cibus traits in the U.S. as modernized regulatory policy for precision gene editing breeding technologies continues to advance globally Designation confirms conventional regulation of Cibus traits in the U.S. as modernized regulatory policy for precision gene editing breeding technologies continues to advance globally |
globenewswire.com |
2025-04-24 13:00:00 |
Czytaj oryginał (ang.) |
| Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript |
Cibus, Inc. (NASDAQ:CBUS ) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Carlo Broos - Interim Chief Financial Officer Peter Beetham - Co-Founder, President and COO, Interim CEO Greg Gocal - Co-Founder and Chief Scientific Officer and Executive Vice President Conference Call Participants Laurence Alexander - Jefferies Austin Moeller - Canaccord Sameer Joshi - H. C. Wainwright Matthew Venezia - Alliance Global Partners Operator Good afternoon, and welcome to the Cibus Fourth Quarter 2024 Results Conference Call. |
seekingalpha.com |
2025-03-20 21:31:13 |
Czytaj oryginał (ang.) |
| Cibus Reports Fourth Quarter Financial Results and Provides Business Update |
A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene editing legislation for the EU; California Rice Commission approved Cibus' field research proposal marking the first time gene edited Rice has been authorized for planting within the state |
globenewswire.com |
2025-03-20 18:05:00 |
Czytaj oryginał (ang.) |
| Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward |
Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene editing, to contribute to more sustainable agriculture, climate resilience, and food security Proposed legislation identifies a ‘conventional-like' category of NGT-1 products that would be regulated as conventional varieties, bringing EU regulation closer to that of other global trading partners The agreement on the Council's negotiating mandate allows its presidency to start negotiations with the European Parliament on the final text of the regulation SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies, welcomes significant progress in the regulation of New Genomic Techniques (NGTs) in the European Union (EU). On Friday 14th March, EU member states endorsed the EU Council's (the “Council”) negotiating mandate on the regulation of plants obtained by NGTs. |
globenewswire.com |
2025-03-17 09:00:00 |
Czytaj oryginał (ang.) |
| Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call |
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2024 financial results on Thursday, March 20, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. |
globenewswire.com |
2025-03-11 09:00:00 |
Czytaj oryginał (ang.) |
| Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola |
Initial bioassay data for Cibus' third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment |
globenewswire.com |
2025-03-04 11:15:00 |
Czytaj oryginał (ang.) |
| Cibus Announces Leadership Change and CEO Succession Plan |
SAN DIEGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced key leadership changes pursuant to the Company's succession planning strategy. The Board has accepted Rory Riggs' resignation as the Company's Chief Executive Officer. Peter Beetham, the Company's President and Chief Operating Officer, also will serve as the Company's Interim Chief Executive Officer. Dr. Beetham is a co-founder of Cibus Global with Mr. Riggs and with Greg Gocal, who will remain the Company's Chief Scientific Officer. Mr. Riggs will remain Chairman of the Board of Directors. Dr. Beetham also will continue as a director. |
globenewswire.com |
2025-02-28 10:30:00 |
Czytaj oryginał (ang.) |
| Cibus Announces Important Update to Rice Gene Editing Conversion Rates |
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today issued a correction relating to the rice conversion rates previously disclosed in its January 16, 2025 press release. The Company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based upon subsequent experiments and high variability in the conversion rate data. |
globenewswire.com |
2025-02-14 09:00:00 |
Czytaj oryginał (ang.) |
| Cibus to Participate in the Sidoti Micro Cap Conference |
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the Sidoti Micro Cap Conference. |
globenewswire.com |
2025-01-22 18:05:00 |
Czytaj oryginał (ang.) |
| Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq Rules |
SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced it has entered into securities purchase agreements with existing investors of the Company, including institutional and strategic investors, as well as with the Company's CEO, Rory Riggs, for the purchase and sale of 9,040,000 shares of its Class A Common Stock (inclusive of pre-funded warrants to purchase shares of Class A Common Stock, in lieu of common stock), and warrants to purchase up to an aggregate of 9,040,000 shares of Class A Common Stock, at a combined purchase price per share (and accompanying warrant) of $2.50 per share ($2.4999 in respect of the pre-funded warrants (and accompanying warrant)), pursuant to a registered direct offering priced above Nasdaq's Minimum Price in accordance with Nasdaq rules. The warrants will be exercisable upon stockholder approval at a price of $2.50 per share, and will expire five years following the date of stockholder approval. Following stockholder approval, the warrants will be redeemable, at the Company's option, at a redemption price of $0.0001 per warrant following the satisfaction of certain conditions, including (i) the Company's announcement of an operational soybean platform and (ii) the closing price of the Class A Common Stock equaling or exceeding $5.00 per share for fifteen consecutive trading days. |
globenewswire.com |
2025-01-21 10:30:00 |
Czytaj oryginał (ang.) |
| Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers |
Cibus' Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S. |
globenewswire.com |
2024-12-16 09:00:00 |
Czytaj oryginał (ang.) |
| Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape |
Cibus and Biographica to collaborate on identifying gene editing targets for Cibus' disease resistance trait development |
globenewswire.com |
2024-11-19 09:30:00 |
Czytaj oryginał (ang.) |
| Cibus to Participate in the 13th Annual Roth Technology Conference |
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will participate in the 13th Annual Roth Technology Conference. |
globenewswire.com |
2024-11-18 09:00:00 |
Czytaj oryginał (ang.) |
| Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript |
Cibus, Inc. (NASDAQ:CBUS ) Q3 2024 Results Conference Call November 7, 2024 4:30 PM ET Company Participants Carlo Broos - Chief Financial Officer Rory Riggs - Co-Founder, Chairman and CEO Peter Beetham - Co-Founder, President and COO Conference Call Participants Laurence Alexander - Jefferies Austin Moeller - Canaccord Matthew Venezia - Alliance Global Partners Operator Good day, and welcome to the Cibus Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. |
seekingalpha.com |
2024-11-09 15:38:09 |
Czytaj oryginał (ang.) |
| Cibus (CBUS) Q3 Earnings and Revenues Top Estimates |
Cibus (CBUS) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.90 per share. This compares to loss of $1.59 per share a year ago. |
zacks.com |
2024-11-07 20:57:39 |
Czytaj oryginał (ang.) |
| Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024 |
Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of weed management platform (HT1 and HT3) for Rice, Pod Shatter Reduction in Canola, Sclerotinia resistance for Canola and Soybean, and on Soybean platform development |
globenewswire.com |
2024-11-07 18:05:00 |
Czytaj oryginał (ang.) |
| Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola |
The greenhouse results represent an important success milestone in the development of its second-generation of HT2 edited Canola |
globenewswire.com |
2024-11-05 10:00:00 |
Czytaj oryginał (ang.) |
| Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call |
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report third quarter 2024 financial results on Thursday, November 7, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. |
globenewswire.com |
2024-10-24 11:00:00 |
Czytaj oryginał (ang.) |
| Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities |
Projected Cost Savings of Approximately $10 Million on Annualized Run-Rate Basis and Expected to Reduce Cash Use by Approximately 20% Projected Cost Savings of Approximately $10 Million on Annualized Run-Rate Basis and Expected to Reduce Cash Use by Approximately 20% |
globenewswire.com |
2024-10-21 11:00:00 |
Czytaj oryginał (ang.) |
| Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress |
SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, has been named a finalist for the Euroseeds2024 InnovActor Award and will have its technology showcased on the InnovAction Stage at the Euroseeds2024 Congress. Cibus' presentation will be given by Dr. Jim Radtke (SVP Product Development) who was recently honored by the American Seed Trade Association (ASTA) with a Lifetime Achievement Award. The event will take place in Copenhagen, Denmark, October 13-16 with the winner named at the 2024 InnovActor Ceremony on October 15. |
globenewswire.com |
2024-10-11 12:49:00 |
Czytaj oryginał (ang.) |
| Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly |
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announced that Peter Beetham, Co-Founder, President and Chief Operating Officer, will participate in a panel discussion titled “Sowing Solutions: Innovations in Climate-Resilient Seeds” at the Food+ Forum during the 79th session of the United Nations General Assembly (“UNGA”) in New York, NY, on Thursday, September 26, at 12:50 pm ET. |
globenewswire.com |
2024-09-23 17:01:00 |
Czytaj oryginał (ang.) |
| Cibus Announces Pricing of Public Offering of Class A Common Stock |
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the pricing of an underwritten public offering of 3,000,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) at a public offering price of $4.00 per share. The Company has granted the underwriters a 45-day option to purchase an additional 450,000 shares of Class A Common Stock to cover over-allotments, if any. All shares of Class A Common Stock to be sold in the offering are to be sold by the Company. |
globenewswire.com |
2024-09-18 12:25:00 |
Czytaj oryginał (ang.) |
| Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock |
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it intends to offer shares of its Class A common stock in an underwritten public offering. Cibus also expects to grant to the underwriters of the offering a 45-day option to purchase up to an additional 15% of the shares of Class A common stock offered in the underwritten public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Certain existing institutional and accredited investors and Rory Riggs, Cibus' Chief Executive Officer, have indicated an interest in purchasing shares of Class A Common Stock in this offering. Because these indications of interest are not binding agreements or commitments to purchase, those certain existing investors and Mr. Riggs may elect not to purchase any shares in this offering, or the underwriters may elect not to sell any shares in this offering to those certain existing investors or Mr. Riggs. |
globenewswire.com |
2024-09-17 20:46:00 |
Czytaj oryginał (ang.) |
| Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape |
Initial data from Pod Shatter Reduction field trials show promising results The first gene edited trait to complete field trials in oilseed rape in the UK SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has completed initial field tests of its Pod Shatter Reduction (PSR) trait in the United Kingdom. |
globenewswire.com |
2024-09-10 11:00:00 |
Czytaj oryginał (ang.) |
| Cibus to Participate in Upcoming August Investor Events |
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announced its participation in the following August investor events. |
globenewswire.com |
2024-08-12 20:05:00 |
Czytaj oryginał (ang.) |
| Cibus, Inc. (CBUS) Q2 2024 Earnings Call Transcript |
Cibus, Inc. (NASDAQ:CBUS ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Wade King - Chief Financial Officer Rory Riggs - Co-Founder, Chairman and CEO Peter Beetham - Co-Founder, President and COO Conference Call Participants Nick Anderson - ROTH Capital Matthew Venezia - Alliance Global Partners Austin Moeller - Canaccord Sameer Joshi - H.C. Wainwright Steve Byrne - Bank of America Operator I'd like to turn the conference over to Wade King, Chief Financial Officer. |
seekingalpha.com |
2024-08-10 15:19:08 |
Czytaj oryginał (ang.) |
| Cibus (CBUS) Reports Q2 Loss, Tops Revenue Estimates |
Cibus (CBUS) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to loss of $3.05 per share a year ago. |
zacks.com |
2024-08-08 23:11:10 |
Czytaj oryginał (ang.) |
| Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice |
Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant traits in an elite variety of rice to improve weed management. |
globenewswire.com |
2024-08-06 11:36:00 |
Czytaj oryginał (ang.) |
| Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call |
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report second quarter 2024 financial results on Thursday, August 8, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. |
globenewswire.com |
2024-08-01 11:00:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS |
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. |
globenewswire.com |
2024-07-26 16:30:00 |
Czytaj oryginał (ang.) |